Trials / Completed
CompletedNCT00338754
Adalimumab in Adult Japanese Subjects With Moderate to Severe Chronic Plaque Psoriasis
A Phase 2/3, Randomized, Double-Blind, Placebo Controlled, Multicenter Study of Efficacy and Safety of Adalimumab in Japanese Subjects With Moderate to Severe Chronic Plaque Psoriasis
- Status
- Completed
- Phase
- Phase 2 / Phase 3
- Study type
- Interventional
- Enrollment
- 160 (planned)
- Sponsor
- Abbott · Industry
- Sex
- All
- Age
- 20 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of the study is to assess the efficacy and safety of repeated administration of adalimumab in adult Japanese subjects with moderate to severe chronic plaque psoriasis.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Human anti-TNF monoclonal antibody adalimumab/ up to 24 weeks |
Timeline
- Start date
- 2005-11-01
- First posted
- 2006-06-20
- Last updated
- 2007-09-11
Locations
8 sites across 1 country: Japan
Source: ClinicalTrials.gov record NCT00338754. Inclusion in this directory is not an endorsement.